---
title: BiPER Therapeutics | Investors-partnership
---

[![logo](https://biper-tx.com/hubfs/Home/logo.png)](https://biper-tx.com/?hsLang=en)

- [Science & Technology](https://biper-tx.com/science?hsLang=en)
- [Pipeline](https://biper-tx.com/science?hsLang=en#pipeline)
- [Investors & Partnership](https://biper-tx.com/investors)
- [Company](https://biper-tx.com/about?hsLang=en)

[Contact us](https://biper-tx.com/?hsLang=en#contact)

[Contact us](https://biper-tx.com/?hsLang=en#contact)

[Home](https://biper-tx.com/?hsLang=en)

# Investors & Partnership

We are moving our unique technology from the lab to the clinic to break down cancer defenses and help patients faster. We invite partners and investors to join us in building a strong future and bringing these new medicines to market.

![pattern](https://biper-tx.com/hubfs/Home/pattern.png)

## Investment Opportunity

![intersect](https://biper-tx.com/hubfs/Investors/intersect.png)

Backed by a seasoned management team and a breakthrough first-in-class pipeline, BiPER Therapeutics is positioned for significant growth.

![intersect](https://biper-tx.com/hubfs/Investors/intersect.png)

With secured Seed financing and strong non-dilutive support, we are executing a strategic development plan focused on delivering key clinical and preclinical milestones.

![intersect](https://biper-tx.com/hubfs/Investors/intersect.png)

We invite visionary investors to join our next phase of expansion.

## Strategic Partnerships

We actively seek collaborations with pharmaceutical and biotech leaders aiming to strengthen their pipelines. Our BiP-targeting technology offers unique synergy potential, particularly in combination strategies designed to overcome drug resistance and revitalize standard-of-care therapies.

![strategic](https://biper-tx.com/hubfs/Investors/strategic.png)

## ![Icon\_doc](https://biper-tx.com/hubfs/Investors/Icon_doc.svg) One Pager

[Know more](https://biper-tx.com/hubfs/Investors/pdf/OnePager_BIPER%20TX_Oct%202025.pdf?hsLang=en)

## Academic Collaboration

Our pipeline is powered by extensive collaborations with premier academic centers. These alliances provide rigorous scientific validation and accelerate the translation of our discoveries into clinical candidates.

![partner1](https://biper-tx.com/hubfs/Home/Partners/partner1.png)

![partner2](https://biper-tx.com/hubfs/Home/Partners/partner2.png)

![partner3](https://biper-tx.com/hubfs/Home/Partners/partner3.png)

![partner4](https://biper-tx.com/hubfs/Home/Partners/partner4.png)

![partner5](https://biper-tx.com/hubfs/Home/Partners/partner5.png)

###### Let’s Pioneer the Future of Treatment

We are always open to discussing new synergies and collaborative opportunities.

[Contact Our Team](https://biper-tx.com/?hsLang=en#contact)

![logo](https://biper-tx.com/hubfs/Home/logo.png)

- [Science & Technology](https://biper-tx.com/science?hsLang=en)
- [Pipeline](https://biper-tx.com/science?hsLang=en#pipeline)
- [Investors & Partnership](https://biper-tx.com/investors)
- [Company](https://biper-tx.com/about?hsLang=en)

[Contact us](https://biper-tx.com/?hsLang=en#contact)

BiPER Therapeutics 32 Allée de la Robertsau 67000 Strasbourg

|

Copyright © BiPER Therapeutics 2026

|

[Legal Notice](https://biper-tx.com/notice?hsLang=en)

[Follow us on LinkedIn](https://www.linkedin.com/company/biper-therapeutics/posts/?feedView=all)